Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis

Background: Bronchiolitis is the most common lower respiratory tract infection in children. The management guidelines recommend only supportive measures; however, there is an increasing burden for bronchiolitis especially in developing countries. The use of nebulized hypertonic saline may aid in dec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hosam Elesh, Hany El-khaleegy, Mohamed elsamanoudy
Formato:	article
Lenguaje:	EN
Publicado:	Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:	nebulization bronchiolitis normal saline hypertonic saline Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c7e8c270741b4998bbbffdb8eaf70fa4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c7e8c270741b4998bbbffdb8eaf70fa4
record_format	dspace
spelling	oai:doaj.org-article:c7e8c270741b4998bbbffdb8eaf70fa42021-12-02T14:49:25ZEfficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis2636-41742682-378010.21608/ijma.2021.42037.1162https://doaj.org/article/c7e8c270741b4998bbbffdb8eaf70fa42021-07-01T00:00:00Zhttps://ijma.journals.ekb.eg/article_172360_91935a253834a3fc0d5045efafe7f578.pdfhttps://doaj.org/toc/2636-4174https://doaj.org/toc/2682-3780Background: Bronchiolitis is the most common lower respiratory tract infection in children. The management guidelines recommend only supportive measures; however, there is an increasing burden for bronchiolitis especially in developing countries. The use of nebulized hypertonic saline may aid in decreasing hospital stay and decrease the global burden of the disease.Objective: To compare between the efficacy of hypertonic saline versus normal saline in reducing duration of hospital admission and improving symptoms of acute bronchiolitis.Patients and methods: A randomized comparative clinical trial included 90 children with acute bronchiolitis, conducted at Al-Azhar University Hospital (New Damietta) during the period from October 2019 till June 2020. Patients were randomly assigned into 2 groups; 45 patients received 3% hypertonic saline nebulization (group 1), and 45 patients received 0.9% normal saline nebulization (group 2). Efficacy of treatment was assessed through duration of hospitalization and oxygen supplementation, and severity of respiratory distress.Results: there was no significant difference between both groups as regard to age, sex, baseline clinical severity score and O2 saturation. After treatment, patients who received nebulized hypertonic saline showed less duration of hospitalization (62.3±20.8 hours vs 76.8± 26.1 hours; p=0.001), less duration of O2 therapy (16.2±6.0 hours vs 25.3±5.4 hours; p=0.01). As regard to severity clinical score, patients received nebulized hypertonic saline showed significant improvement started within 24 hours from admission (P=<0.001).Conclusions: Nebulized hypertonic 3% saline is effective in reducing hospital stay among children with bronchiolitis compared with nebulized normal saline. Further large studies are required to confirm these results.Hosam EleshHany El-khaleegyMohamed elsamanoudyAl-Azhar University, Faculty of Medicine (Damietta)articlenebulizationbronchiolitisnormal salinehypertonic salineMedicine (General)R5-920ENInternational Journal of Medical Arts, Vol 3, Iss 3, Pp 1584-1588 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	nebulization bronchiolitis normal saline hypertonic saline Medicine (General) R5-920
spellingShingle	nebulization bronchiolitis normal saline hypertonic saline Medicine (General) R5-920 Hosam Elesh Hany El-khaleegy Mohamed elsamanoudy Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
description	Background: Bronchiolitis is the most common lower respiratory tract infection in children. The management guidelines recommend only supportive measures; however, there is an increasing burden for bronchiolitis especially in developing countries. The use of nebulized hypertonic saline may aid in decreasing hospital stay and decrease the global burden of the disease.Objective: To compare between the efficacy of hypertonic saline versus normal saline in reducing duration of hospital admission and improving symptoms of acute bronchiolitis.Patients and methods: A randomized comparative clinical trial included 90 children with acute bronchiolitis, conducted at Al-Azhar University Hospital (New Damietta) during the period from October 2019 till June 2020. Patients were randomly assigned into 2 groups; 45 patients received 3% hypertonic saline nebulization (group 1), and 45 patients received 0.9% normal saline nebulization (group 2). Efficacy of treatment was assessed through duration of hospitalization and oxygen supplementation, and severity of respiratory distress.Results: there was no significant difference between both groups as regard to age, sex, baseline clinical severity score and O2 saturation. After treatment, patients who received nebulized hypertonic saline showed less duration of hospitalization (62.3±20.8 hours vs 76.8± 26.1 hours; p=0.001), less duration of O2 therapy (16.2±6.0 hours vs 25.3±5.4 hours; p=0.01). As regard to severity clinical score, patients received nebulized hypertonic saline showed significant improvement started within 24 hours from admission (P=<0.001).Conclusions: Nebulized hypertonic 3% saline is effective in reducing hospital stay among children with bronchiolitis compared with nebulized normal saline. Further large studies are required to confirm these results.
format	article
author	Hosam Elesh Hany El-khaleegy Mohamed elsamanoudy
author_facet	Hosam Elesh Hany El-khaleegy Mohamed elsamanoudy
author_sort	Hosam Elesh
title	Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
title_short	Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
title_full	Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
title_fullStr	Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
title_full_unstemmed	Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
title_sort	efficacy of nebulized hypertonic saline 3% in comparison to nebulized normal saline 0.9% in children with acute bronchiolitis
publisher	Al-Azhar University, Faculty of Medicine (Damietta)
publishDate	2021
url	https://doaj.org/article/c7e8c270741b4998bbbffdb8eaf70fa4
work_keys_str_mv	AT hosamelesh efficacyofnebulizedhypertonicsaline3incomparisontonebulizednormalsaline09inchildrenwithacutebronchiolitis AT hanyelkhaleegy efficacyofnebulizedhypertonicsaline3incomparisontonebulizednormalsaline09inchildrenwithacutebronchiolitis AT mohamedelsamanoudy efficacyofnebulizedhypertonicsaline3incomparisontonebulizednormalsaline09inchildrenwithacutebronchiolitis
_version_	1718389474729132032

Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis

Ejemplares similares